temozolomide has been researched along with 2-hydroxy-9-cis-octadecenoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barceló-Coblijn, G; Busquets, X; Escribá, PV; García-Verdugo, JM; Gómez-Pinedo, U; Higuera, M; Lladó, V; Marcilla-Etxenike, A; Martin, ML; Noguera-Salvà, MA; Saus, C; Soriano-Navarro, M; Terés, S | 1 |
1 other study(ies) available for temozolomide and 2-hydroxy-9-cis-octadecenoic acid
| Article | Year |
|---|---|
2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy.
Topics: Animals; Antineoplastic Agents; Autophagy; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Survival; Dacarbazine; Dose-Response Relationship, Drug; Glioma; Humans; Male; MAP Kinase Signaling System; Membrane Lipids; Mice; Mice, Nude; Microscopy, Confocal; Oleic Acids; Phosphatidylinositol 3-Kinases; Protein Transport; Proto-Oncogene Proteins c-akt; ras Proteins; Temozolomide; Time Factors; Xenograft Model Antitumor Assays | 2012 |